Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI platform aims to unlock Real-World cancer data on a massive scale

NCT ID NCT07756034

Recruiting now Knowledge-focused Sponsor: Tempus AI Source: ClinicalTrials.gov ↗

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This study enrolls people diagnosed with cancer to build a large registry using Olivia, an AI-powered health platform. The platform will collect and combine electronic health records and patient-reported outcomes from over 1,000 healthcare systems. The goal is to create a comprehensive, real-world dataset to support cancer research and potentially improve care. Sub-studies may be added to explore specific research questions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this registry could create a rich, real-world data resource to accelerate cancer research and personalize care.
What could go wrong
This is an observational registry, not a treatment trial, so it won't directly test a new therapy. Data quality and completeness may vary across the many participating sites.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer childhood acute myeloid leukemia hematopoietic and lymphoid system neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER HEMATOLOGIC MALIGNANCIES PEDIATRIC ACUTE MYELOID LEUKEMIA SOLID TUMOR CANCER

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Tempus AI

    RECRUITING

    Chicago, Illinois, 60654, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.